Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2006 2
2008 2
2009 2
2010 1
2011 2
2012 3
2013 2
2014 2
2015 1
2016 1
2017 1
2018 1
2019 3
2020 5
2021 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Management of paroxysmal nocturnal haemoglobinuria: a personal view.
Luzzatto L, Gianfaldoni G, Notaro R. Luzzatto L, et al. Among authors: gianfaldoni g. Br J Haematol. 2011 Jun;153(6):709-20. doi: 10.1111/j.1365-2141.2011.08690.x. Epub 2011 Apr 22. Br J Haematol. 2011. PMID: 21517820 Free article. Review.
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia.
Mannelli F, Piccini M, Bencini S, Gianfaldoni G, Peruzzi B, Caporale R, Scappini B, Fasano L, Quinti E, Ciolli G, Pasquini A, Crupi F, Pilerci S, Pancani F, Signori L, Tarantino D, Maccari C, Paradiso V, Annunziato F, Guglielmelli P, Vannucchi AM. Mannelli F, et al. Among authors: gianfaldoni g. Haematologica. 2024 Jan 1;109(1):60-71. doi: 10.3324/haematol.2023.283196. Haematologica. 2024. PMID: 37345475 Free PMC article.
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial.
Gianfaldoni G, Mannelli F, Intermesoli T, Bencini S, Giupponi D, Farina G, Cutini I, Bonetti MI, Masciulli A, Audisio E, Ferrero D, Pavoni C, Scattolin AM, Bosi A, Rambaldi A, Bassan R. Gianfaldoni G, et al. Blood Adv. 2020 Jan 28;4(2):301-311. doi: 10.1182/bloodadvances.2019000406. Blood Adv. 2020. PMID: 31978214 Free PMC article. Clinical Trial.
AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trial.
Mannelli F, Gianfaldoni G, Guglielmelli P, Buccisano F, Caporale R, Chiarini M, Rossi G, Venditti A, Fazi P, Crea E, Piciocchi A, Voso MT, Vignetti M, Amadori S, Vannucchi AM. Mannelli F, et al. Among authors: gianfaldoni g. Future Oncol. 2021 Oct;17(29):3787-3796. doi: 10.2217/fon-2021-0388. Epub 2021 Jul 13. Future Oncol. 2021. PMID: 34254530 Clinical Trial.
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML.
Bassan R, Intermesoli T, Masciulli A, Pavoni C, Boschini C, Gianfaldoni G, Marmont F, Cavattoni I, Mattei D, Terruzzi E, De Paoli L, Cattaneo C, Borlenghi E, Ciceri F, Bernardi M, Scattolin AM, Todisco E, Campiotti L, Corradini P, Cortelezzi A, Ferrero D, Zanghì P, Oldani E, Spinelli O, Audisio E, Cortelazzo S, Bosi A, Falini B, Pogliani EM, Rambaldi A. Bassan R, et al. Among authors: gianfaldoni g. Blood Adv. 2019 Apr 9;3(7):1103-1117. doi: 10.1182/bloodadvances.2018026625. Blood Adv. 2019. PMID: 30948365 Free PMC article. Clinical Trial.
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06.
Caprioli C, Lussana F, Salmoiraghi S, Cavagna R, Buklijas K, Elidi L, Zanghi' P, Michelato A, Delaini F, Oldani E, Intermesoli T, Grassi A, Gianfaldoni G, Mannelli F, Ferrero D, Audisio E, Terruzzi E, De Paoli L, Cattaneo C, Borlenghi E, Cavattoni I, Tajana M, Scattolin AM, Mattei D, Corradini P, Campiotti L, Ciceri F, Bernardi M, Todisco E, Cortelezzi A, Falini B, Pavoni C, Bassan R, Spinelli O, Rambaldi A. Caprioli C, et al. Among authors: gianfaldoni g. Haematologica. 2021 Oct 1;106(10):2578-2587. doi: 10.3324/haematol.2020.252825. Haematologica. 2021. PMID: 32855275 Free PMC article. Clinical Trial.
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia.
Mannelli F, Cutini I, Gianfaldoni G, Bencini S, Scappini B, Pancani F, Ponziani V, Bonetti MI, Biagiotti C, Longo G, Bosi A. Mannelli F, et al. Among authors: gianfaldoni g. Cytometry B Clin Cytom. 2014 Sep;86(5):340-9. doi: 10.1002/cyto.b.21156. Epub 2014 Feb 5. Cytometry B Clin Cytom. 2014. PMID: 24500843 Free article.
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemia.
Mannelli F, Gianfaldoni G, Bencini S, Piccini M, Cutini I, Bonetti MI, Scappini B, Pancani F, Ponziani V, Chiarini M, Borlenghi E, Bassan R, Rossi G, Bosi A. Mannelli F, et al. Among authors: gianfaldoni g. Am J Hematol. 2020 Nov;95(11):1304-1313. doi: 10.1002/ajh.25942. Epub 2020 Aug 19. Am J Hematol. 2020. PMID: 32697337 Free article. Clinical Trial.
30 results